Kosher Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 7.00 Cr
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 17.46 Cr
- Revenue Growth 135.26%
- Profit Growth 84.92%
- Ebitda 254.96%
- Net Worth -384.56%
- Total Assets 12.02%
About Kosher Pharmaceutical
Kosher Pharmaceutical Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 29 March 2012 and has a history of 12 years and ten months. Its registered office is in Hyderabad, Telangana.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company has closed loans amounting to ₹17.46 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pallavi Reddy and Thirupathi Lakkireddy serve as directors at the Company.
Company Details
- Location Hyderabad, Telangana
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2012PTC080005
-
Company No.
080005
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Mar 2012
-
Date of AGM
08 Jul 2021
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Kosher Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Reddy
|
Director | 29-Mar-2012 | Current |
|
Thirupathi Lakkireddy
|
Director | 07-Nov-2015 | Current |
Financial Performance of Kosher Pharmaceutical.
Kosher Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 135.26% increase. The company also saw a substantial improvement in profitability, with a 84.92% increase in profit. The company's net worth observed a substantial decline by a decrease of 384.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kosher Pharmaceutical?
In 2020, Kosher Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ltr Life Sciences Private LimitedPallavi Reddy and Thirupathi Lakkireddy are mutual person
Charges (Loans)
₹0
₹17.46 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 17.46 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2017 | Canara Bank | ₹17.46 Cr | Satisfied |
How Many Employees Work at Kosher Pharmaceutical?
Kosher Pharmaceutical has a workforce of 3 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kosher Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kosher Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
